NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

鐮狀細胞性貧血測試和篩選的全球市場:技術,年齡組,行業市場研究,預測(∼2025年),COVID-19的累積影響

Sickle Cell Anemia Testing & Screening Market Research Report by Technology, by Age Group, by Sector, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 995321
出版日期 內容資訊 英文 180 Pages
商品交期: 最快1-2個工作天內
價格
鐮狀細胞性貧血測試和篩選的全球市場:技術,年齡組,行業市場研究,預測(∼2025年),COVID-19的累積影響 Sickle Cell Anemia Testing & Screening Market Research Report by Technology, by Age Group, by Sector, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 180 Pages
簡介

全球鐮狀細胞性貧血測試和篩查市場預計將從2020年的7.265億美元增長到2025年底的128.356億美元。

預計COVID-19將在預測期內對行業增長產生長期影響,因為這是無與倫比的全球公共衛生突發事件,幾乎影響了每個行業。我們正在進行的研究擴大了研究框架,以確保它包括潛在的COVID-19問題和潛在的未來路徑。該調查提供了有關COVID-19的見解,並考慮了消費者行為和需求,購買模式,供應鏈改路,當前市場勢力動態以及政府的主要干預措施的變化。更新後的調查提供了見解,分析,估計和預測,其中考慮了COVID-19對市場的影響。

本報告對鐮狀細胞性貧血的測試和篩選,市場概況,市場增長和抑制因素的分析,市場機會,COVID-19的影響,技術,年齡段和行業的全球市場進行了調查。市場規模趨勢和按地區,競爭狀況和主要公司的概況進行的預測。

目錄

第1章簡介

  • 調查目的
  • 市場細分和覆蓋範圍
  • 考慮調查的年份
  • 貨幣和價格
  • 語言
  • 限制
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 公式:數據驗證
    • 已發佈:調查報告
    • 重複:報告更新
  • 進行調查
    • 開始:調查過程
    • 計劃:創建調查計劃
    • 執行:進行調查
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 市場前景
  • 年齡段展望
  • 技術展望
  • 行業前景
  • 區域展望
  • 競爭對手展望

第4章市場概述

  • COVID-19的累積效果

第5章市場洞察

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
    • 挑戰
  • 波特五力分析
    • 新進入者的威脅
    • 替代威脅
    • 客戶的議價能力
    • 供應商的談判能力
    • 行業競爭

第6章按技術

  • 血紅蛋白電泳
    • 等電聚焦
  • 高效液相色譜(HPLC)
  • 護理點檢查
    • 免疫色譜
    • 紙質快速診斷

第7章(按年齡段)

  • 成人篩查(25-60歲)
  • 新生兒篩查(12個月或更短)
  • 其他年齡段(1至25歲,60歲以上)

按部門劃分的第8章

  • 企業研究所
  • 政府研究所
  • PPP(公私合營)
  • 私人研究所

第9章美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第11章歐洲,中東/非洲

  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第12章競爭情況

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場份額分析
  • 競爭性SWOT分析
  • 競爭情況
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 獎賞,表彰,擴展

第13章企業可用性概況

  • Anmol Laboratories Pvt. Ltd.
  • Atlas Medical
  • BabyFirstTest
  • Bio-Rad Laboratories, Inc.
  • BIOMEDOMICS INC.
  • Cleveland Clinic
  • Clin Tech Ltd
  • Edvotek
  • Elsevier Inc.
  • Health Union LLC
  • Hemex Health
  • HemoTypeSC
  • HiMedia Laboratories
  • Himedia Labs
  • Laboratory Corporation of America Holdings
  • LabTestsOnline
  • PerkinElmer Inc.
  • PicnicHealth
  • Quest Diagnostics Incorporated
  • SickleDex
  • SickleScan
  • Silver Lake Research Corporation
  • STRECK
  • Thalassaemia and Sickle Cell Australia
  • Ulta Lab Test

第14章附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-A339DAEFA38E

The Global Sickle Cell Anemia Testing & Screening Market size was estimated at USD 712.65 Million in 2020 and expected to reach USD 805.21 Million in 2021, at a Compound Annual Growth Rate (CAGR) 13.32% to reach USD 1,509.63 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Sickle Cell Anemia Testing & Screening to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Technology, the Sickle Cell Anemia Testing & Screening Market was studied across Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC), and Point-of-Care Tests. The Hemoglobin Electrophoresis is further studied across Isoelectric focusing. The Point-of-Care Tests is further studied across Lateral Flow Immunoassay and Paper Based Rapid Diagnostics.

Based on Age Group, the Sickle Cell Anemia Testing & Screening Market was studied across Adult Screening (25 to 60 years), Newborn Screening (12 months and below), and Other Age Groups (1 to 25 & above 60 years).

Based on Sector, the Sickle Cell Anemia Testing & Screening Market was studied across Corporate Labs, Government Labs, PPP (Public-Private-Partnerships), and Private Labs.

Based on Geography, the Sickle Cell Anemia Testing & Screening Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Sickle Cell Anemia Testing & Screening Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Sickle Cell Anemia Testing & Screening Market, including Anmol Laboratories Pvt. Ltd., Atlas Medical, BabyFirstTest, Bio-Rad Laboratories, Inc., BIOMEDOMICS INC., Cleveland Clinic, Clin Tech Ltd, Edvotek, Elsevier Inc., Health Union LLC, Hemex Health, HemoTypeSC, HiMedia Laboratories, Himedia Labs, Laboratory Corporation of America Holdings, LabTestsOnline, PerkinElmer Inc., PicnicHealth, Quest Diagnostics Incorporated, SickleDex, SickleScan, Silver Lake Research Corporation, STRECK, Thalassaemia and Sickle Cell Australia, and Ulta Lab Test.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Sickle Cell Anemia Testing & Screening Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Sickle Cell Anemia Testing & Screening Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Sickle Cell Anemia Testing & Screening Market?
  • 4. What is the competitive strategic window for opportunities in the Global Sickle Cell Anemia Testing & Screening Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Sickle Cell Anemia Testing & Screening Market?
  • 6. What is the market share of the leading vendors in the Global Sickle Cell Anemia Testing & Screening Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Sickle Cell Anemia Testing & Screening Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Age Group Outlook
  • 3.4. Technology Outlook
  • 3.5. Sector Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of sickle cell disease
      • 5.1.1.2. Initiatives taken by Government supporting diagnosis
      • 5.1.1.3. Significant rise in adult screening segment
    • 5.1.2. Restraints
      • 5.1.2.1. Chances of infections due to lack of resources
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing deep learning framework designed to perform automated screening of sickle cell anemia
      • 5.1.3.2. Rising focus on Point of care testing
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of infrastructure required for sickle cell anemia testing and screening
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Sickle Cell Anemia Testing & Screening Market, by Technology

  • 6.1. Introduction
  • 6.2. Hemoglobin Electrophoresis
    • 6.2.1. Isoelectric focusing
  • 6.3. High-performance Liquid Chromatography (HPLC)
  • 6.4. Point-of-Care Tests
    • 6.4.1. Lateral Flow Immunoassay
    • 6.4.2. Paper Based Rapid Diagnostics

7. Sickle Cell Anemia Testing & Screening Market, by Age Group

  • 7.1. Introduction
  • 7.2. Adult Screening (25 to 60 years)
  • 7.3. Newborn Screening (12 months and below)
  • 7.4. Other Age Groups (1 to 25 & above 60 years)

8. Sickle Cell Anemia Testing & Screening Market, by Sector

  • 8.1. Introduction
  • 8.2. Corporate Labs
  • 8.3. Government Labs
  • 8.4. PPP (Public-Private-Partnerships)
  • 8.5. Private Labs

9. Americas Sickle Cell Anemia Testing & Screening Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Sickle Cell Anemia Testing & Screening Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Sickle Cell Anemia Testing & Screening Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Anmol Laboratories Pvt. Ltd.
  • 13.2. Atlas Medical
  • 13.3. BabyFirstTest
  • 13.4. Bio-Rad Laboratories, Inc.
  • 13.5. BIOMEDOMICS INC.
  • 13.6. Cleveland Clinic
  • 13.7. Clin Tech Ltd
  • 13.8. Edvotek
  • 13.9. Elsevier Inc.
  • 13.10. Health Union LLC
  • 13.11. Hemex Health
  • 13.12. HemoTypeSC
  • 13.13. HiMedia Laboratories
  • 13.14. Himedia Labs
  • 13.15. Laboratory Corporation of America Holdings
  • 13.16. LabTestsOnline
  • 13.17. PerkinElmer Inc.
  • 13.18. PicnicHealth
  • 13.19. Quest Diagnostics Incorporated
  • 13.20. SickleDex
  • 13.21. SickleScan
  • 13.22. Silver Lake Research Corporation
  • 13.23. STRECK
  • 13.24. Thalassaemia and Sickle Cell Australia
  • 13.25. Ulta Lab Test

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2026
  • FIGURE 11. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HEMOGLOBIN ELECTROPHORESIS, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HEMOGLOBIN ELECTROPHORESIS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY ISOELECTRIC FOCUSING, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY ISOELECTRIC FOCUSING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC), 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC), BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY POINT-OF-CARE TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PAPER BASED RAPID DIAGNOSTICS, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PAPER BASED RAPID DIAGNOSTICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2020 VS 2026 (%)
  • FIGURE 24. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2026
  • FIGURE 26. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY ADULT SCREENING (25 TO 60 YEARS), 2018-2026 (USD MILLION)
  • FIGURE 27. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY ADULT SCREENING (25 TO 60 YEARS), BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY NEWBORN SCREENING (12 MONTHS AND BELOW), 2018-2026 (USD MILLION)
  • FIGURE 29. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY NEWBORN SCREENING (12 MONTHS AND BELOW), BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY OTHER AGE GROUPS (1 TO 25 & ABOVE 60 YEARS), 2018-2026 (USD MILLION)
  • FIGURE 31. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY OTHER AGE GROUPS (1 TO 25 & ABOVE 60 YEARS), BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 32. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2020 VS 2026 (%)
  • FIGURE 33. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2020 VS 2026 (USD MILLION)
  • FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2026
  • FIGURE 35. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CORPORATE LABS, 2018-2026 (USD MILLION)
  • FIGURE 36. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CORPORATE LABS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GOVERNMENT LABS, 2018-2026 (USD MILLION)
  • FIGURE 38. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GOVERNMENT LABS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 39. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PPP (PUBLIC-PRIVATE-PARTNERSHIPS), 2018-2026 (USD MILLION)
  • FIGURE 40. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PPP (PUBLIC-PRIVATE-PARTNERSHIPS), BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 41. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRIVATE LABS, 2018-2026 (USD MILLION)
  • FIGURE 42. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRIVATE LABS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 43. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 44. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 46. ARGENTINA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. BRAZIL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. CANADA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. MEXICO SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. UNITED STATES SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. CALIFORNIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. FLORIDA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. ILLINOIS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. NEW YORK SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. OHIO SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. PENNSYLVANIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. TEXAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 59. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 61. CHINA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. INDIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. INDONESIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. JAPAN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. MALAYSIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. PHILIPPINES SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. SOUTH KOREA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. THAILAND SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 70. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 71. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 72. FRANCE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. GERMANY SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. ITALY SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. NETHERLANDS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 76. QATAR SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. RUSSIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 78. SAUDI ARABIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 79. SOUTH AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 80. SPAIN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 81. UNITED ARAB EMIRATES SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 82. UNITED KINGDOM SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 83. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: FPNV POSITIONING MATRIX
  • FIGURE 84. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 85. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 86. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HEMOGLOBIN ELECTROPHORESIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY ISOELECTRIC FOCUSING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY POINT-OF-CARE TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PAPER BASED RAPID DIAGNOSTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY ADULT SCREENING (25 TO 60 YEARS), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY NEWBORN SCREENING (12 MONTHS AND BELOW), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY OTHER AGE GROUPS (1 TO 25 & ABOVE 60 YEARS), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CORPORATE LABS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GOVERNMENT LABS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PPP (PUBLIC-PRIVATE-PARTNERSHIPS), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRIVATE LABS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. ARGENTINA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. ARGENTINA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ARGENTINA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. BRAZIL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. BRAZIL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. BRAZIL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. CANADA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. CANADA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. CANADA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. MEXICO SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. MEXICO SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. MEXICO SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. UNITED STATES SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. UNITED STATES SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. UNITED STATES SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. UNITED STATES SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. CALIFORNIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. CALIFORNIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. CALIFORNIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. FLORIDA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. FLORIDA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. FLORIDA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. ILLINOIS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. ILLINOIS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. ILLINOIS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. NEW YORK SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. NEW YORK SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. NEW YORK SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. OHIO SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. OHIO SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. OHIO SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. PENNSYLVANIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. PENNSYLVANIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. PENNSYLVANIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. TEXAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. TEXAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. TEXAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. CHINA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. CHINA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. CHINA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. INDIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. INDIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. INDIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. INDONESIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. INDONESIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. INDONESIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. JAPAN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. JAPAN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. JAPAN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. MALAYSIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. MALAYSIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. MALAYSIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. PHILIPPINES SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. PHILIPPINES SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. PHILIPPINES SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. SOUTH KOREA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. SOUTH KOREA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. SOUTH KOREA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. THAILAND SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. THAILAND SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. THAILAND SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. FRANCE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. FRANCE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. FRANCE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. GERMANY SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. GERMANY SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. GERMANY SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. ITALY SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. ITALY SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. ITALY SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. NETHERLANDS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. NETHERLANDS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. NETHERLANDS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. QATAR SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. QATAR SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. QATAR SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. RUSSIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. RUSSIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. RUSSIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SAUDI ARABIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SAUDI ARABIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SAUDI ARABIA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. SOUTH AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. SOUTH AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. SOUTH AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. SPAIN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. SPAIN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. SPAIN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. UNITED ARAB EMIRATES SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. UNITED ARAB EMIRATES SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. UNITED ARAB EMIRATES SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. UNITED KINGDOM SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY AGE GROUP, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. UNITED KINGDOM SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. UNITED KINGDOM SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SECTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: SCORES
  • TABLE 126. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: BUSINESS STRATEGY
  • TABLE 127. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: PRODUCT SATISFACTION
  • TABLE 128. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: RANKING
  • TABLE 129. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 130. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: SHARE, BY COMPANY, 2020
  • TABLE 131. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: MERGER & ACQUISITION
  • TABLE 132. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 133. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 134. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: INVESTMENT & FUNDING
  • TABLE 135. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 136. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: LICENSE & PRICING
  • TABLE 137. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET: CONTACT DETAILS